2023-10-07 15:42:00
This cooperation between AstraZeneca Thailand and Bangkok is considered to continue the goal of increasing The Lung Ambition Alliance (LAA) aims to double the ‘five-year survival rate’ of patients by 2025, jointly formed between four international partners: AstraZeneca, the Global Lung Cancer Coalition (GLCC) Guardant Health and the International Association for the Study of Lung Cancer (IASLC) conduct activities to support mission achievement in 50 countries around the world. Including Thailand To study and understand the evolution of the disease. Developing advanced techniques for treating lung cancer. Through promoting primary screening for lung cancer to increase the chances of effective early detection using AI technology, which will allow patients to live longer. Including having a better quality of life
Mr. Roman Ramos, President of AstraZeneca Thailand, said: “AstraZeneca Committed to improving the quality of life of patients Through the use of scientific advancements to expand and develop sustainable health care for people, communities, and the world. Cancer is one of the main diseases that we continually focus on. We have researched, invented, and supported innovations that will help improve the efficiency of early disease diagnosis through the use of AI technology. This approach is in line with the current public health path of Thailand, which wants to create innovations and advance care. digital health From this cooperation We aim to provide primary lung cancer screening to more than 500,000 people by 2024 to increase the chance of survival for patients.”
AI technology or “qXR” software installed in this project It was developed by Qure.ai, an AI solution company, which is one of AstraZeneca’s partners supporting the use of technology and innovation to help improve early screening for lung cancer. This solution has been registered by the Food and Drug Administration. To be an artificial intelligence medical tool that uses deep learning capabilities to identify up to 29 abnormalities from lung X-ray images, including the size and location of lumps. or signs of symptoms that may accurately indicate lung cancer
Mr. Prashant Warrior, CEO and co-founder of Qure.ai, said: “This partnership leverages Qure’s cutting-edge AI technology, “qXR,” to analyze chest X-ray images. This is part of the initial screening program to identify lung cancer risk. It plays an important role in detecting lung nodules, which may be an early indicator of lung cancer. Once a suspicious lung mass has been identified Patients will receive a CT scan immediately for further diagnosis and timely treatment planning.”
Details of the mobile screening point and affiliated hospitals in Bangkok
Charoenkrung Pracharak Hospital Sirindhorn Hospital Rajphiphat Hospital Luangphor Thaweesak Chutintharo Uthit Hospital, Lat Krabang Hospital, Bangkok Mobile health inspection unit, Department of Health
and many more hospitals under Bangkok in the future
1696808435
#AstraZeneca #Thailand #Bangkok #sign #Dont #Wait #Checked
